Literature DB >> 17969037

Liver fibrosis: the hepatocyte revisited.

Mark D Gorrell1.   

Abstract

Entities:  

Year:  2007        PMID： 17969037     DOI： 10.1002/hep.22003

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

1.  Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.

Authors:  Xiao-Wei Zhang; Ji-Chao Zhou; Dian Peng; Fang Hua; Ke Li; Jiao-Jiao Yu; Xiao-Xi Lv; Bing Cui; Shan-Shan Liu; Jin-Mei Yu; Feng Wang; Cai-Cai Jin; Zhao-Na Yang; Chen-Xi Zhao; Xue-Ying Hou; Bo Huang; Zhuo-Wei Hu
Journal:  Autophagy       Date:  2019-07-09       Impact factor: 16.016

2.  Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis.

Authors:  Ryan E Feaver; Banumathi K Cole; Mark J Lawson; Stephen A Hoang; Svetlana Marukian; Brett R Blackman; Robert A Figler; Arun J Sanyal; Brian R Wamhoff; Ajit Dash
Journal:  JCI Insight       Date:  2016-12-08

3.  Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development.

Authors:  Efstathios Vassiliadis; Natasha Barascuk; Morten A Karsdal
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

4.  Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl(4)-induced hepatic fibrosis in mice.

Authors:  Zhi-Ming Hao; Min Cai; Yi-Fei Lv; Yan-Hua Huang; Hong-Hong Li
Journal:  Mol Ther       Date:  2012-07-31       Impact factor: 11.454

5.  A simple and efficient method to isolate macrophages from mixed primary cultures of adult liver cells.

Authors:  Hiroshi Kitani; Takato Takenouchi; Mitsuru Sato; Miyako Yoshioka; Noriko Yamanaka
Journal:  J Vis Exp       Date:  2011-05-24       Impact factor: 1.355

6.  Baicalin Ameliorates Experimental Liver Cholestasis in Mice by Modulation of Oxidative Stress, Inflammation, and NRF2 Transcription Factor.

Authors:  Kezhen Shen; Xiaowen Feng; Hao Pan; Feng Zhang; Haiyang Xie; Shusen Zheng
Journal:  Oxid Med Cell Longev       Date:  2017-07-05       Impact factor: 6.543

Review 7.  mRNA and gene editing: Late breaking therapies in liver diseases.

Authors:  Nerea Zabaleta; Laura Torella; Nicholas D Weber; Gloria Gonzalez-Aseguinolaza
Journal:  Hepatology       Date:  2022-04-01       Impact factor: 17.298

8.  Reversible conversion of epithelial and mesenchymal phenotypes in SV40 large T antigen-immortalized rat liver cell lines.

Authors:  Takato Takenouchi; Miyako Yoshioka; Noriko Yamanaka; Hiroshi Kitani
Journal:  Cell Biol Int Rep (2010)       Date:  2010-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.